Insulet Corporation
$ 141.17
1.34%
07 Aug - close price
- Market Cap 9,790,732,000 USD
- Current Price $ 141.17
- High / Low $ 142.22 / 136.46
- Stock P/E 26.09
- Book Value 20.52
- EPS 5.41
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.26 %
- 52 Week High 354.88
- 52 Week Low 126.40
About
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Analyst Target Price
$171.91
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-05 | 2026-05-06 | 2026-02-18 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-20 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-22 | 2023-11-02 |
| Reported EPS | 1.66 | 1.42 | 1.55 | 1.24 | 1.17 | 1.02 | 1.15 | 0.9 | 0.55 | 0.73 | 1.4 | 0.71 |
| Estimated EPS | 1.44 | 1.19 | 1.48 | 1.15 | 0.93 | 0.79 | 1.021 | 0.76 | 0.56 | 0.39 | 0.66 | 0.41 |
| Surprise | 0.22 | 0.23 | 0.07 | 0.09 | 0.24 | 0.23 | 0.129 | 0.14 | -0.01 | 0.34 | 0.74 | 0.3 |
| Surprise Percentage | 15.2778% | 19.3277% | 4.7297% | 7.8261% | 25.8065% | 29.1139% | 12.6347% | 18.4211% | -1.7857% | 87.1795% | 112.1212% | 73.1707% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PODD
2026-08-08 13:38:57
Insulet Corporation's stock dropped 15% to US$141 despite reporting revenues in line with expectations and slightly better-than-expected statutory profits of US$1.37 per share. Analysts maintained their 2026 revenue and EPS forecasts at US$3.29 billion and US$6.17, respectively, but cut the consensus price target by 27% to US$172, indicating reduced optimism about the company's intrinsic value. Despite the price target reduction, Insulet is still projected to grow faster than the wider medical equipment industry.
2026-08-08 08:37:53
Beacon Investment Advisory Services Inc. reduced its stake in Insulet Corporation (NASDAQ:PODD) by 13.3% in the second quarter, now holding 59,333 shares valued at approximately $9.03 million. Despite Insulet reporting strong second-quarter revenues and adjusted EPS that beat analyst expectations, the company lowered its 2026 revenue outlook due to weaker retention among Type 2 diabetes users, leading analysts to cut price targets. Investor concerns have also been raised by product recalls and a proposed securities lawsuit.
2026-08-07 23:37:54
Faruqi & Faruqi, LLP is reminding investors of the August 31, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made false and misleading statements about defective manufacturing controls which led to two product recalls and significant stock price drops. Investors who purchased Insulet securities between February 21, 2025, and May 26, 2026, are encouraged to contact the firm to discuss their legal options.
2026-08-07 23:11:28
Faruqi & Faruqi, LLP is investigating potential claims against Insulet Corporation (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges Insulet made false and/or misleading statements regarding defective manufacturing controls, leading to product recalls and significant stock price drops. Investors who purchased Insulet securities between February 21, 2025, and May 26, 2026, are encouraged to contact the firm.
2026-08-07 21:11:28
This article provides financial data for Insulet Corporation (HAM:GOV) specifically focusing on its non-operating income (total). The data is presented within the context of the Hamburg Stock Exchange, though no specific values are listed in the provided content. It serves as a placeholder for financial figures on TradingView.
2026-08-07 20:38:53
This article displays the "Net current asset value per share" for Insulet Corporation (GOV) on the Hamburg Stock Exchange. The current financial data for the specified period is not available, showing "No trades" as the market is closed. The content primarily consists of navigation and product links for the TradingView platform.
